ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses4.93 M5.32 M4.93 M5.24 M6.79 M22.28 MResearch & development20.28 M19.43 M21.15 M17.46 M16.49 M74.54 MOperating income-25.21 M-24.76 M-26.08 M-22.69 M-23.28 M-96.82 MNon-Operating Income, Total240 K1.02 M-1.81 M-22.91 M-20.44 M-44.14 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses250 K1.04 M-1.79 M-22.9 M-20.43 M-44.09 MUnusual income/expense-10 K-21 K-15 K-6 000-11 K-53 KPretax income-24.97 M-23.73 M-27.89 M-45.6 M-43.73 M-140.95 MEquity in earnings——————Taxes————-8.59 M—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations-24.97 M-23.73 M-27.89 M-45.6 M-43.73 M-140.95 MDiscontinued operations——————Net income-24.97 M-23.73 M-27.89 M-45.6 M-43.73 M-140.95 MDilution adjustment0—————Preferred dividends0—————Diluted net income available to common stockholders-24.97 M-23.73 M-27.89 M-45.6 M-43.73 M-140.95 MBasic earnings per share (Basic EPS)-0.61-0.49-0.57-0.71-0.09-1.86Diluted earnings per share (Diluted EPS)-0.61-0.49-0.57-0.71-0.09-1.86Average basic shares outstanding43.54 M48.87 M49.04 M64.65 M75.82 M238.38 MDiluted shares outstanding43.54 M48.87 M49.04 M64.65 M75.82 M238.38 MEBITDA-24.99 M-24.47 M-25.81 M-22.4 M-23 M-95.69 MEBIT-25.21 M-24.76 M-26.08 M-22.69 M-23.28 M-96.82 MCost of revenue000000Other cost of goods sold——————Depreciation & amortization (cash flow)223 K290 K270 K290 K279 K1.13 M
Fractyl Health Inc
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.